Vor Biopharma company info

What does Vor Biopharma do?
Vor Biopharma (NASDAQ:VOR) focuses on revolutionizing the treatment of cancer by modifying patients' hematopoietic stem cells to make them invisible to targeted therapies, potentially reducing or eliminating the side effects of these treatments. Its operations are primarily centered on the research and development of pioneering cell therapies aimed at improving the lives of patients battling cancer. Among its projects is the innovative VOR33, a treatment designed to facilitate targeted cancer therapy with minimized harm to non-cancerous cells. Vor Biopharma's objectives include advancing its research into clinical trials, expanding its portfolio of cell therapy candidates, and forging partnerships that enhance its technological capabilities and accelerate the development of its therapies. Through these endeavors, Vor Biopharma seeks to deliver groundbreaking treatments that transform cancer care.
Vor Biopharma company media
Company Snapshot

Is Vor Biopharma a public or private company?

key
Ownership
Public

How many people does Vor Biopharma employ?

people
Employees
168

What sector is Vor Biopharma in?

pie chart
Sector
Health Care

Where is the head office for Vor Biopharma?

location pin
Head Office
Cambridge, United States

What year was Vor Biopharma founded?

founded flag
Year Founded
2015
What does Vor Biopharma specialise in?
/Cell Therapies /Cancer Treatment /Hematopoietic Stem Cells /In Vivo Validation /VOR33 Program /Human Applications

What are the products and/or services of Vor Biopharma?

Overview of Vor Biopharma offerings
Engineered hematopoietic stem cell (eHSC) therapies targeting blood cancers.
VOR33, a treatment designed to remove CD33-expressing cells to enable targeted therapies.
Collaborations to develop CAR-T cell therapies enhancing adoptive cell transfer treatments.
Research in gene editing technologies to improve safety and efficacy of cell-based therapies.
Developing antibody-based drugs for precise targeting of cancer cells.
Partnerships aimed at advancing the manufacturing and scalability of cell therapies.

Who is in the executive team of Vor Biopharma?

Vor Biopharma leadership team
  • Dr. Robert  Ang M.B.A., M.D., MBBS
    Dr. Robert Ang M.B.A., M.D., MBBS
    President, CEO & Director
  • Ms. Tania  Philipp
    Ms. Tania Philipp
    Chief People Officer
  • Dr. Robert G. Pietrusko Pharm. D., Pharm.D.
    Dr. Robert G. Pietrusko Pharm. D., Pharm.D.
    Chief Regulatory Officer
  • Mr. John C. King M.B.A.
    Mr. John C. King M.B.A.
    Chief Commercial Officer
  • Dr. Eyal C. Attar M.D.
    Dr. Eyal C. Attar M.D.
    Chief Medical Officer
  • Mr. Samir  Vattompadam M.S.
    Mr. Samir Vattompadam M.S.
    Senior Vice President of Portfolio Strategy & Program Management
  • Mr. David  Phillips M.B.A.
    Mr. David Phillips M.B.A.
    Senior VP & Head of Quality